Home Blog Page 82

Godrej Industries Q2 FY26 Consolidated Revenue Up 23%, Profits Dip

Godrej Industries reported a 23% increase in consolidated total income to ₹6,290 crore for Q2 FY26. PBDIT rose by 41% to ₹1,428 crore, while net profit decreased by 16% to ₹242 crore. Godrej Properties’ booking value grew significantly, and Godrej Agrovet’s animal feed segment achieved record volumes. Astec LifeSciences’ rights issue was completed, increasing shareholding to 67.03%.

Financial Performance

Godrej Industries announced its financial results for Q2 FY26, showcasing a mixed performance across its various segments. The consolidated total income reached ₹6,290 crore, marking a significant increase of 23% compared to the previous year. Profit Before Depreciation, Interest, and Taxes (PBDIT) also saw substantial growth, climbing 41% to ₹1,428 crore.

However, the company’s net profit experienced a decline, decreasing by 16% to ₹242 crore. This dip was attributed to several factors, including temporary headwinds affecting Godrej Consumer Products Limited (GCPL).

Segment Highlights

Chemicals: Reported a 29% increase in revenue with exports accounting for approximately 27% of revenue for the quarter.

Real Estate (Godrej Properties): Booking value grew 64% year-on-year and 20% quarter-on-quarter to ₹8,505 crore, driven by the sale of 4,522 homes. The company added 4 new projects and received 56 awards.

Agri Business (Godrej Agrovet Limited): The Animal Feed segment achieved record quarterly volumes. However, crop protection revenues witnessed a decrease to ₹213 crore.

Strategic Developments

Godrej Agrovet increased its stake in Creamline Dairy Products Limited, now holding 99.78% equity. The rights issue of Astec LifeSciences Limited, a subsidiary of Godrej Agrovet, was completed, increasing Godrej Agrovet’s shareholding to 67.03% as of September 30, 2025.

The group divested a 2.5% equity stake in Vivrut Developers Private Limited, resulting in a gain of ₹5.35 crores, which was recognized under Other Income.

Leadership Commentary

N.B. Godrej, Chairman and Managing Director, noted strategic movements regarding joint ventures, impacting Other Income positively. He also drew attention to acquisitions impacting comparisons with non-controlling interests.

Source: BSE

Sun Pharma Q2 FY26 Earnings Call Highlights Increased Revenue and R&D

Sun Pharma announced its Q2 FY26 results, showcasing an 8.6% sales growth, reaching INR144,052 million. The company’s EBITDA increased by 14.9% to INR45,271 million, with a margin of 31.3%. Global Innovative Medicines sales rose by 16.4% to USD313 million. The company continues to invest in R&D, with a focus on innovative medicines and expansion in key markets.

Financial Performance Overview

Sun Pharmaceutical Industries Limited reported strong financial results for Q2 FY26. Key highlights include:

  • Sales: INR144,052 million, an increase of 8.6% compared to Q2 FY25.
  • Gross Margin: 79.3% for the quarter.
  • EBITDA: INR45,271 million, up by 14.9% year-over-year.
  • EBITDA Margin: 31.3%.
  • Net Profit After Tax: INR31,180 million, a 2.6% increase.
  • EPS: INR13 per share.

For the first half of the fiscal year, sales reached INR2,81,913 million, representing a 9.3% growth. The EBITDA for the first half was INR88,287 million, a 17% increase.

Global Innovative Medicines

Global Innovative Medicines sales increased by 16.4% to USD313 million. U.S. sales of Innovative Medicines surpassed generics for the first time this quarter.

ILUMYA, a key brand, is now available in 35 markets.

India Business

Formulation sales in India were INR47,348 million, representing an 11% growth. India’s Formulation sales accounted for 32.9% of total consolidated sales for the quarter. Sun Pharma holds 8.3% market share in the Indian pharmaceutical market.

U.S. Business

The overall U.S. business declined by 4.1% to $496 million for the quarter. This decline was partially offset by growth in Innovative Medicines.

R&D Investments

Consolidated investments in R&D for Q2 FY26 were INR7,827 million, or 5.4% of sales. Innovative R&D accounted for 38% of the total R&D spend.

The company awaits FDA decision on UNLOXCYT updated labeling and remains on track to launch UNLOXCYT in the U.S. in the second half of FY ’26. Plans are underway to file ILUMYA psoriatic arthritis sBLA during the second half of FY ’26.

Source: BSE

Jupiter Wagons Q2 FY26 Revenue Jumps 71% QoQ

Jupiter Wagons reported strong Q2 FY26 results with revenue up 71% QoQ to ₹786 Crore, driven by improved wheelset supply. EBITDA increased by 73% QoQ to ₹104 Crore. The company’s other business verticals are scaling up performance, and Jupiter Electric Mobility (JEM) is gaining momentum with its battery energy storage solutions. The railwheel factory also secured significant orders.

Financial Performance

In Q2 FY26, Jupiter Wagons’ revenue from operations reached ₹786 Crore, a substantial 71% increase compared to the previous quarter. This growth was primarily fueled by an improved supply of wheelsets for its wagons business. The company’s EBITDA for Q2 FY26 stood at ₹104 Crore, marking a 73% rise QoQ. The EBITDA margin was 13.2%. The company reported a PAT of ₹45 Crore, with a PAT Margin of 5.8%. EPS for Q2 FY26 is ₹1.10 per share.

H1 FY26 Highlights

For the first half of fiscal year 2026, Jupiter Wagons reported revenue from operations of ₹1,245 Crore. EBITDA for H1 FY26 was ₹163 Crore. The EBITDA Margin was 13.1%. PAT for H1 FY26 reached ₹76 Crore, with a PAT Margin of 6.1%. EPS for H1 FY26 is ₹1.87 per share.

Operational Developments

Jupiter Electric Mobility (JEM) introduced 10 ft and 20 ft containerized Battery Energy Storage Systems (BESS). The company delivered its first 10 ft BESS unit to Greenlit and is preparing for its first 20 ft unit export. Six new JEM Dealerships were opened in Hyderabad, Delhi, Ghaziabad, Pune, Ahmedabad and Trivandrum. Jupiter Tatravagonka Railwheel Factory received an order from the Ministry of Railways for 9,000 LHB axles and a Letter of Intent for 5,376 wheelsets for the Vande Bharat project. The company’s forged axle and wheel facility in Odisha is progressing rapidly.

Order Book

The order book stands at ₹5,538 Crore as of September 30, 2025.

Source: BSE

Jupiter Wagons Reports Strong Q2 & H1 FY26 Financial Results

Jupiter Wagons Limited (JWL) announced its Q2 and H1 FY26 financial results, reporting a total income of ₹1,272 crore and a profit after tax (PAT) of ₹76 crore for H1 FY26. Q2 FY26 saw a 71% increase in income compared to Q1 FY26, driven by improved wheelset availability. The company’s EBITDA also increased by 73% on a quarter-over-quarter basis.

Financial Highlights for Q2 & H1 FY26

Jupiter Wagons Limited reported strong financial performance for the second quarter and first half of FY26:

  • Total Income: ₹1,272 crore for H1 FY26.
  • Profit After Tax (PAT): ₹76 crore for H1 FY26.

Q2 FY26 Performance

The company experienced significant growth in Q2 FY26:

  • Consolidated income increased by 71% to ₹786 crore compared to Q1 FY26, driven by improved wheelset availability in the wagons business.
  • Consolidated EBITDA rose by 73% quarter-over-quarter, reaching ₹104 crore.
  • EBITDA margins improved from 13% in Q1 FY26 to 13.2% in Q2 FY26.

Key Developments

Several key developments contributed to the company’s performance:

  • Jupiter Electric Mobility (JEM) launched 10 ft and 20 ft containerised Battery Energy Storage Systems (BESS).
  • Jupiter Tatravagonka Railwheel Factory secured an order worth ₹215 crore for Vande Bharat wheelsets and another order for ₹113 crore for Axle supply.

Order Book

As of September 30, 2025, the company’s order book stands at ₹5,538 crore.

Jupiter Electric Mobility (JEM) Updates

JEM launched modular containerised BESS (10 ft & 20 ft) with capacities from 241 kWh to 3 MWh. They also opened six new dealerships across India – Hyderabad, Delhi, Ghaziabad, Pune, Ahmedabad and Thirvandrum.

Jupiter Tatravagonka Railwheel Factory (JWL) Updates

JWL secured an order of ₹113 crore from the Ministry of Railways for 9,000 LHB axles. They also received a Letter of Intent for ₹215 crore for 5,376 wheelsets for the Vande Bharat project.

Source: BSE

Godrej Industries Q2 FY26 Consolidated Revenue Up 23% to ₹6,290 Crore

Godrej Industries reported strong Q2 FY26 results, with consolidated total income rising by 23% to ₹6,290 crore. PBDIT increased by 41% to ₹1,428 crore, while PBIT grew by 44% to ₹1,307 crore. Net profit stood at ₹242 crore. Key segments like chemicals and estate development contributed significantly to this growth. The company also highlighted significant appreciation in its investment values.

Financial Performance

Godrej Industries announced its Q2 FY26 results, showcasing substantial growth across key financial metrics:

  • Total Income: ₹6,290 crore (up 23% year-over-year)
  • PBDIT: ₹1,428 crore (up 41% year-over-year)
  • PBIT: ₹1,307 crore (up 44% year-over-year)
  • Net Profit: ₹242 crore

Segmental Highlights

The company’s performance was driven by strong contributions from various segments:

  • Chemicals: Revenue increased by 29%.
  • Estate and Property Development: Showed significant growth, contributing substantially to the overall revenue.

Subsidiary Performance

Key subsidiaries also reported notable results:

  • Godrej Consumer Products (GCPL): Consolidated sales grew by 4% in INR.
  • Godrej Properties Limited (GPL): Booking value grew 64% year-over-year.
  • Godrej Agrovet Limited (GAVL): Reported solid performance, with animal feed segment driving volumes.

Investment Value Appreciation

Godrej Industries highlighted a significant appreciation in the value of its investments, with a total investment value of ₹8,643 crore as of September 30, 2025. Key investments include:

  • Godrej Consumer Products (GCPL): Market value of ₹28,328 crore.
  • Godrej Properties (GPL): Market value of ₹26,567 crore.
  • Godrej Agrovet: Market value of ₹8,616 crore.

Source: BSE

Axis Bank Revised Investor Presentation on Financial Results for Q2 FY26

Axis Bank has revised its investor presentation on the financial results for the quarter and half year ended September 30, 2025 (Q2 FY26). The updated presentation, correcting business information on Slide 21, is now available on the bank’s website. The bank has apologized for any inconvenience and reaffirmed its commitment to accuracy.

Investor Presentation Update

Axis Bank announced a revision to its investor presentation related to the financial results for Q2 FY26, which ended on September 30, 2025. The initial presentation has been updated to reflect corrections to business information on Slide 21.

Accessing the Revised Presentation

The revised investor presentation is now accessible on the Axis Bank website at the following link:

https://www.axis.bank.in/shareholders-corner/financial-results-and-other-presentation

Commitment to Transparency

Axis Bank has expressed apologies for any inconvenience caused by this revision and has reaffirmed its commitment to maintaining accuracy and transparency in its disclosures. This update ensures that all stakeholders have access to the most current and correct information regarding the bank’s performance.

Source: BSE

Bharat Forge Kalyani Strategic Systems Secures ₹2,500 Mn Underwater Systems Contract

Kalyani Strategic Systems Ltd (KSSL), a subsidiary of Bharat Forge, has been awarded contracts worth over ₹2,500 Mn to supply underwater systems to the Indian MoD. The contract, signed on November 10, 2025, requires delivery within a year, aligning with Fast Track procurement norms. KSSL is enhancing its capabilities in naval guns and marine equipment to meet the Indian Navy’s requirements.

KSSL Wins Major Defense Contract

Kalyani Strategic Systems Ltd (KSSL) has secured contracts from the Indian Ministry of Defence (MoD) for the supply of underwater systems. The total value of the contracts exceeds ₹2,500 Mn, highlighting KSSL’s growing role in the defense sector.

Contract Details and Timeline

The contracts were officially signed on November 10, 2025, with a stipulated delivery timeframe of one year. This means the systems are to be delivered by November 2026, in accordance with the Fast Track procurement guidelines.

KSSL’s Capabilities in Marine Systems

KSSL, a wholly-owned subsidiary of Bharat Forge, focuses on defence business initiatives and has been building its capacity in unmanned marine systems. Over the past 5 years, KSSL has developed design, development, and production capabilities, even supplying autonomous underwater vehicles that are already in use by the Indian Navy.

Strategic Focus on Underwater Domain

The underwater domain is a key area for KSSL, which is actively expanding its capabilities to align with the Indian Navy’s needs. This includes naval guns and other marine equipment, demonstrating a commitment to timely delivery of advanced solutions.

Source: BSE

PI Industries Approves Unaudited Financial Results for Quarter Ended September 30, 2025

PI Industries has announced the approval of its unaudited standalone and consolidated financial results for the quarter ended September 30, 2025. The Board of Directors approved the results during a meeting on November 11, 2025. Both standalone and consolidated results show substantial revenue and profit figures, highlighting the company’s strong performance. Detailed financial figures are enclosed within the report.

Financial Performance Highlights

PI Industries reported strong financial results for the second quarter of fiscal year 2026. Key highlights from the unaudited standalone results include:

  • Revenue from operations: ₹17,526 Million
  • Total Income: ₹18,329 Million
  • Profit before tax: ₹6,146 Million
  • Profit for the period: ₹4,911 Million
  • Earnings per share: ₹32.36

Consolidated Financial Performance

The consolidated financial results also indicate a strong performance for the quarter ended September 30, 2025. Key figures from the unaudited consolidated results include:

  • Revenue from operations: ₹18,723 Million
  • Total Income: ₹19,548 Million
  • Profit before tax: ₹5,253 Million
  • Profit for the period: ₹4,093 Million
  • Earnings per share: ₹26.98

Segment Highlights

The company’s revenue is divided into two main segments, with the following figures for the quarter ended September 30, 2025:

  • Agro chemicals: ₹18,092 Million
  • Pharma: ₹634 Million

Additional Information

The company has fully utilized funds raised through a Qualified Institutional Placement (QIP) as of September 30, 2025, with significant investments made in subsidiaries (₹18,419 Million) and capital expenditure (₹1,331 Million).

Source: BSE

Balrampur Chini Mills Reports Healthy Q2 FY26 Performance with Strong Sugar & Distillery Growth

Balrampur Chini Mills Limited (BCML) announced positive Q2 FY26 results driven by improvements in both sugar and distillery divisions. The company reported higher volumes and better realizations, resulting in enhanced profitability. The revision in power tariff, effective April 1, 2024, also contributed positively. An interim dividend of ₹3.50 per share was declared.

Financial Performance Overview

Balrampur Chini Mills Limited (BCML) has reported a healthy performance for Q2 FY26, demonstrating improvement in both volumes and realizations across its sugar and distillery divisions. The company’s profitability was also supported by a favorable revision in power tariffs.

Key Financial Highlights for Q2 FY26

  • Revenue from Operations: ₹1670.76 crores, up 28.72%.
  • EBITDA (excluding Other Income): ₹120.40 crores, up 145.31%.

H1 FY26 Performance

  • Revenue from Operations: ₹3213.04 crores, an increase of 18.15%.
  • EBITDA (excluding Other Income): ₹254.65 crores, reflecting an 18.32% rise.

Dividend Announcement

The Board of Directors has declared an interim dividend of ₹3.50 per equity share, resulting in an outflow of approximately ₹70.7 crores.

Future Outlook

India’s net sugar production is projected to rebound in the 2025-26 season, estimated at 31 MMT, a 19% increase from the previous season’s 26.1 MMT. The company anticipates increased production volumes due to favorable weather conditions.

Polylactic Acid (PLA) Project Update

The company is making significant progress on its Polylactic Acid (PLA) project, with construction activities in full swing. As of October 31, 2025, approximately ₹1093 crores have been invested in the project.

Source: BSE

PI Industries Q2 FY26 Results – Consolidated Net Profit at ₹4,093 Million

PI Industries announced its Q2 FY26 results, showcasing a consolidated net profit of ₹4,093 million. Revenue from operations reached ₹18,723 million. The company’s expenses totaled ₹14,316 million. The board approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The company’s shares earned ₹26.98 per share.

Financial Performance Highlights

PI Industries (PI Industries Ltd) has released its unaudited consolidated financial results for Q2 FY26. Key highlights from the report include:

  • Revenue from Operations: ₹18,723 million
  • Total Income: ₹19,548 million
  • Profit Before Tax: ₹5,253 million
  • Net Profit: ₹4,093 million
  • Earnings per share:₹26.98

These results reflect the company’s performance for the quarter ended September 30, 2025, as compared to previous financial periods.

Segment Performance

A breakdown of revenue by business segment for Q2 FY26:

  • Agro Chemicals: ₹18,092 million
  • Pharma: ₹634 million

Balance Sheet Overview

As of September 30, 2025, the company’s assets and liabilities include:

  • Total Equity: ₹1,08,269 million
  • Total Assets: ₹1,33,009 million

This data offers insight into the company’s financial standing at the close of Q2 FY26.

Source: BSE